Pulse استكشاف nav.journalClub النقاشات الرائج الباحثون المجلات

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

الرئيسية استكشاف nav.journalClub الرائج

⌘+K

January 4, 2024Open Access

View Full Paper

Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors

JVJuraj VelcickyNovartis (Switzerland)PJPhilipp JanserNovartis (Switzerland)NGNina GommermannNovartis (Switzerland)

Key Points

Key points are not available for this paper at this time.

Abstract

shows also a good overall development profile.

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

View Full Paper

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

View Full Paper

Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors | Synapse

Cite This Study

Velcicky et al. (Thu,) studied this question.

synapsesocial.com/papers/6a0277537247e11d6d512cc4 https://doi.org/https://doi.org/10.1021/acs.jmedchem.3c02098

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Reactions of 3‐benzylindole‐2‐carbohydrazides: Synthesis of new 10‐Benzyl‐1,2‐dihydro‐1‐oxo‐1,2,4‐triazino[4,5‐<i>a</i>]indoles and 3‐Benzyl‐2‐(1,3,4‐oxadiazol‐2‐yl)indoles2004 · 8 citations
2Generation of a Set of Simple, Interpretable ADMET Rules of Thumb2008 · 966 citations
3Immunobiology: the immune system in health and disease1995 · 4,153 citations
4Cyclen based lanthanide ion ribonuclease mimics: the effect of pyridine cofactors upon phosphodiester HPNP hydrolysis2005 · 30 citations
5Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders2023 · 68 citations